Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.230
-0.050 (-3.91%)
At close: Apr 28, 2026, 4:00 PM EDT
1.290
+0.060 (4.88%)
Pre-market: Apr 29, 2026, 5:03 AM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $51.95 million as of April 28, 2026. Its market cap has decreased by -75.22% in one year.
Market Cap
51.95M
Enterprise Value
38.56M
1-Year Change
-75.22%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $51.95M, a decrease of -96.10%. That is a compound annual growth rate of -44.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensus Healthcare | 65.19M |
| Baird Medical Investment Holdings | 64.27M |
| LENSAR | 63.02M |
| Spectral AI | 62.38M |
| InspireMD | 58.28M |
| Phaos Technology Holdings (Cayman) Limited | 56.51M |
| PAVmed | 53.05M |
| Accuray | 52.81M |